Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma.
- Published in:
- Journal of Asthma, 2016, v. 53, n. 2, p. 187, doi. 10.3109/02770903.2015.1070862
- By:
- Publication type:
- Article
Works matching AU Iverson, Harald
Results: 7
1
2
Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma.
- Published in:
- Allergy & Asthma Proceedings, 2017, v. 38, n. 1, p. 28, doi. 10.2500/aap.2017.38.4015
- By:
- Publication type:
- Article
3
Pharmacokinetics and pharmacodynamics of albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane in children with asthma.
- Published in:
- Allergy & Asthma Proceedings, 2016, v. 37, n. 5, p. 370, doi. 10.2500/aap.2016.37.3985
- By:
- Publication type:
- Article
4
Albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane versus placebo in children with persistent asthma.
- Published in:
- Allergy & Asthma Proceedings, 2016, v. 37, n. 5, p. 350, doi. 10.2500/aap.2016.37.3986
- By:
- Publication type:
- Article
5
Prospective, open-label evaluation of a new albuterol multidose dry powder inhaler with integrated dose counter.
- Published in:
- Allergy & Asthma Proceedings, 2016, v. 37, n. 3, p. 199, doi. 10.2500/aap.2016.37.3938
- By:
- Publication type:
- Article
6
Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter.
- Published in:
- Allergy & Asthma Proceedings, 2013, v. 34, n. 1, p. 42, doi. 10.2500/aap.2012.33.3647
- By:
- Publication type:
- Article
7
Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 1, p. 55, doi. 10.1007/s40261-015-0346-y
- By:
- Publication type:
- Article